Tuberculosis (BCG) Vaccine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Two Randomized Controlled Trials of Bacillus Calmette-Gu érin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trials
The objectives of these two separate trials are: (1) to reduce health care workers (HCWs) absenteeism; and (2) to reduce hospital admission among the elderly during the COVID-19 pandemic through BCG vaccination.Trial designTwo separate multi-centre placebo-controlled parallel group randomized trialsParticipants(1) Health care personnel working in the hospital or ambulance service where they will take care of patients with the COVID-19 infection and (2) elderly ≥60 years. The HCW trial is being undertaken in 9 hospitals. The elderly trial is being undertaken in locations in the community in Nijmegen, Utrecht, and Veghel, ...
Source: Trials - June 4, 2020 Category: Research Source Type: clinical trials

Reducing COVID-19 Related Hospital Admission in Elderly by BCG Vaccination
Condition: COVID-19 Interventions: Biological: BCG vaccine; Biological: Placebo Sponsor: Radboud University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2020 Category: Research Source Type: clinical trials

Efficacy of BCG Vaccination in the Prevention of COVID19 Via the Strengthening of Innate Immunity in Health Care Workers
Conditions: Infection; Viral, Agent as Cause of Disease Classified Elsewhere Interventions: Biological: BCG GROUP; Other: PLACEBO GROUP Sponsor: Assistance Publique - Hôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 12, 2020 Category: Research Source Type: clinical trials